NCT03016013 2024-09-26A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects with Inadequate Response to MTX Due to Treat Moderate and Severe Rheumatoid Arthritis.RemeGen Co., Ltd.Phase 3 Completed479 enrolled